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GLAUCOMA is an umbrella term for eye the UK. Those at risk are advised to have a their prescriptions a secone! time. Patient's 
conditions which damage to optic nerve dilated eye examination at least once a education and communication must be 
and which can lead to a loss of vision. The year. ongoing to sustain successful treatment 
main cause of damage to the optic nerve is ., plans for this lifelong disease with no early 
intraocular pressure, excessive fluid pres- Treatment and outcome symptoms. 
, sure with the eye, which can be due to var- The modern goals of glaucoma man-
ious reasons including blockage of agement are to .avoid glaucomatous dam-
drainage ducts, and narrowing or closure age and nerve damage and preserve visual 
of angle between the iris and cornea. The field and total quality of life for patients; 
primary division in categorising different with mirumal side effects. This requires ap-
forms (types) of glaucoma is open angle propriate diagnostic techniques and fol-
and closed angle (or angle closure) glau- low up examinations and 'selection of 
coma. In open angle glaucoma, the iris treatments for the individual patient. AI-
meets the cornea normally, allowing the though intraocular pressure is the , only 
fluid from inside the eye to drain, thus, re- major risk factor for glaucoma, lowering it 
lieving the internal pressure. Where this via various pharmaceuticals and! or surgi-
angle is narrowed or closed, pressure in- cal techniques is currently the mainstay of 
creases over time, causing damage to the glaucoma treatment. Vascular flow and 
optic nerve, leading to blindness. Primary neurodegenerative theories of glaucoma-
. open angle glaucoma (also, primary glau- tous optic neuropathy have prompted 
coma, chronic glaucoma) refers to slow studies on various neuroprotective thera· 
clogging of the drainage canals resulting peutic strategies, including nutritional 
in increased eye pressure which causes compounds, some of which may be re-
progressive optic nerve damage. This man- garded by the clinicians as safe for use 
ifests as a gradual loss of visual fluid, start- now, while others are on trial. 
ing with a loss of peripheral vision, but Intr,aocular pressure can be lowered 
eventually the entire will be lost if not with medications, usually eye drops. Sev-
treated. This is the most common type of eral classes of medications are used to 
glaucoma, accounting for 90 per cent of treat glaucoma, with several medications 
the cases in the United States, but fewer ip in each class. Each of this medicine may 
Asian countries. Onset is slow and pain- have.1ocal or systemic side effects. Adher-
less, and loss of vision is gradual and irre- ence to medication protocol can be con-
versible. Narrow angle glaucoma (also fusing and expensive; if side effects occur, 
closed angle glaucoma) the iris bows for- the patient must be willing either to toler-
ward, narrowing the angle that drains the ate them or to. communicate with the 
eye, increasing pressure within the eye. If treating physician to improve the drug 
untreated, it can lead to the medical emer- regimen. Initially, glaucoma drops may 
gency of angle closure glaucoma. reasonably be started either in one or both 
Screening 
The United States Preventive Task Force 
as of 2013 states there is insufficient evi-
dence to recolnmend for or against screen-
ing glaucoma: Therefore, there is no 
national programme in the US. Screening, 
however, is recommended starting at age 
40 by American Academy of Ophthalmol-
ogy. There is a glaucoma programme in 
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eyes. Wiping the eye with an absorbent 
pad after the administration of eye drops 
may result in fewer adverse effects, W(e the 
growth of eyelashes and hyperpigmenta-
tion in the eyelid. Poor compliance with 
medications and follow-up visits is a major 
reason for vision loss in glaucoma pa-
tients. A 2003 study of patients in an HMO 
found half failed to fill their prescriptions 
the first time, and one fourth failed to refill 
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Laser therapy , 
Argon laser trabeculoplasty (ALT) may 
be used to treat open angle glaucoma but 
this is 'a temporary solution, and not a 
cure. A50-um argon laser spot is aimed at 
the trabecular meshwork to stim'!llate the 
opening of the mesh to allow more out-
flow of aqueous fluid. Usually, half of the 
angle is treated at a time. Traditional laser 
trabeculoplasty uses a thermal argon laser 
in an argon laser trabeculoplastY proce-
dure. A newer type of laser trabeculos-
plasty uses a "cold" (nonthermal) laser to 
stimulate drainage in the trabecular mesh-
work. This newer procedure, selective laser 
trabeculoplasty (SLT) uses a 532-nm fre-
quency double-switched Nd:YAG laser, 
which selectively targets melanin pigment 
in the trabecular meshwork cells. Studies 
show SLT is as effective as ALT at lowering 
eye pressure. In addition, SLT may be re-
peilted three to four times, whereas ALT at 
lowering eye pressure. 
In addition, SLT may be repeated three 
to four times, whereas ALT at lowering eye 
pressure. In addition, SLT may be repeated 
three to four times, whereas ALT can usu-
ally be repeated only once. Nd:YAG laser 
peripheral iridology (LPI) may be used in 
patients susceptible to or affected by angle 
closure glaucoma or pigment dispersion 
syndrome. 
During laser iridology, laser energy is 
used to make a small full-thiclmess open-
ing, in the iris to equalise the pressure be-
tween the front and back of iris, thus 
correcting any abnormal bulging of the 
iris. In people with narrow angles, this cart 
uncover the trabecular meshwork. In some 
cases of intermittent or short-term angle 
closure, this may lower the eye pressure. 
'Laser iridology reduces the risk of devel-
oping chronie angle closure. In most cases 
it also reduces the risk of developing 
chronic angle closure or adhesions of iris 
to the trabecular meshwork. Diode laser 
cycloablation lowers lOP by reducing 
aqueous secretion by destroying secretory , 
ciliary epithelium. ' 
Treatment by surgery 
Both laser and conventional surgeries 
are performed to treat glaucoma (above). 
Surgery is the primary therapy for those 
with congenital glaucoma. Generally these 
operations are temporary solution, as 
there is not yet a cure for glaucoma. 
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Canatoplasty is a non-penetrating proce-
dure using micro catheter technology. By 
opening the canal, the pressure inside the 
eye may be relieved, although the reason 
is unclear, since the canal (of Schlemm) 
does not have any fluid resistance in glau-
coma or healthy eyes. Long term results 
are not avail. Trabeculactomy is the most 
common conventional surgery performed 
for glaucoma. Glaucoma drainage im-
plants were developed by Professor An-
thony Molteno, as the first glaucoma 
drainage implant, in Cape Town in 1966. 
These implants are indicated for glaucoma 
patients not responding to maximal med-
ical therapy, which previous failed 
guarded filtering surgery (trabelectomy). 
Laser-assisted non-penetrating deep scle-
rectomy (NPDS): The most common sur-
gical approach currently used for the 
treatment of glaucoma is turbelectomy, in 
which sclera is punctured to alleviate in-
traocular pressure. NPDS surgery is simi-
lar, but modified, procedure, in which 
instead of puncturing the scleral bed and 
trabecular meshwork under a scleral flap, 
a second deep scleral flap is created, ex-
cised, with further procedures of deroof-
ing the Schlemm's canal, upon which, 
percolation of liquid from the inner eye is 
achieved and, thus, alleviating pressure, 
without penetrating the eye. NPDS is 
demonstrated to have significantly. fewer 
side effects than trabeculatomy. 
Prognosis 
In op~n angle glaucoma, the typical 
progression from normal vision to com-
plete blindness takes 25 to 70 years with- , 
out treatment, depending on the method 
of estimation used. The intraocular pres-
sure can also have an effect, with higher 
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pressure reducing time until blindness. 
Conclusions 
Glaucoma is painless, slow progressive 
vision loss to complete blindness over an 
, extended period. Loss of vision is perma-
nent. Increased eye pressure that leads to 
optic nerve damage is co'ntributory factor. 
There is no known cure for glaucoma. ' 
Summary 
Glaucoma is the leadingcause ofblind~ 
ness after cataract. Individuals of Asian de-
scent are prone to angle closure glaucoma 
due to shallower anterior chamber depths. 
People with family history of glaucoma are 
at higher risk. The major risk factor for 
glaucoma is the increased intraocular 
pressure. Early signs of glaucoma are grad-
ual progressive visual field loss and optic 
. nerve changes. The diagnosis for glau-
coma includes measurement of the in-
traocular pressure via tonometry. The aims 
of glaucoma management are to avoid 
glaucomatous damage and nerve damage 
and preserve visual field and quality of life 
for patients. Poor compliance with med-
ications and follow-up visits is a major rea-
son for vision loss in glaucoma patients. 
Both laser and conventional surgeries are 
performed to treat glaucoma. The intraoc-
ular pressure can also have an effect, with 
higher pressure reducing time until blind-
ness. 
. Information provided in this 
paper is for the general information 
of readers only and not medical advice. 
People with signs and symptoms of 
glaucoma mentioned above should 
seek prompt treatment from medical 
professionals. 
